Migraine News and Research

Latest Migraine News and Research

Migraines not associated with cognitive decline

Migraines currently affect about 20 percent of the female population, and while these headaches are common, there are many unanswered questions surrounding this complex disease. Previous studies have linked this disorder to an increased risk of stroke and structural brain lesions, but it has remained unclear whether migraines had other negative consequences such as dementia or cognitive decline.

12 Aug 2012

Fainting appears to have strong genetic predisposition

Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.

7 Aug 2012

Caffeine may ease movement symptoms of Parkinson's

While drinking caffeine each day does not appear to help improve sleepiness among people with Parkinson's disease, it may have a benefit in controlling movement, according to new research published in the August 1, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

3 Aug 2012

Health Union releases results of 'Migraine In America 2012' study

Health Union, LLC, released the results of its landmark study "Migraine In America 2012" tonight via a live web conference.

31 Jul 2012

Insomnia: an interview with Dr Darryle Schoepp

Insomnia is a very common disorder. In medical terms it can affect a third of people. It affects elderly as well as non-elderly people, and is more common in women.

26 Jul 2012

Watching YouTube videos may help treat benign paroxysmal positional vertigo

Watching videos on YouTube may be a new way to show the treatment for a common cause of vertigo, which often goes untreated by physicians, according to a study published in the July 24, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology.

24 Jul 2012

New AAN guideline recommends several treatments for people with Huntington's chorea

A new guideline released by the American Academy of Neurology recommends several treatments for people with Huntington's disease who experience chorea—jerky, random, uncontrollable movements that can make everyday activities challenging.

19 Jul 2012

High ceramide levels may increase a person's risk of AD

Higher levels of a certain fat in the blood called ceramides may increase a person's risk of developing Alzheimer's disease, according to a study published in the July 18, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Jul 2012

Vivus receives FDA approval for Qsymia to manage chronic weight

The U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management.

18 Jul 2012

Migraine involves multiple symptoms that vary widely among sufferers

Almost everyone suffers from headache pain occasionally, but for 36 million Americans, intense, debilitating headaches accompanied by other neurological symptoms — also known as migraine syndrome — are a source of physical misery that can have a devastating effect on their quality of life. It is estimated that the medical expenses and loss of productivity caused by migraine costs Americans $20 billion annually.

14 Jul 2012

Stress management program may help people with MS prevent new disease activity

A new study shows that taking part in a stress management program may help people with multiple sclerosis (MS) prevent new disease activity. The study is published in the July 11, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

12 Jul 2012

Non-invasive absolute intracranial pressure value meter shown to be accurate in clinical settings

The results of independent clinical assessment – prospective study of innovative non-invasive absolute intracranial pressure (ICP) value (mmHg) meter were recently published in the journal Neurology (The official journal of the American Academy of Neurology). This is the first prospective comparative clinical study of a non-invasive ICP measurement method that shows accuracy and precision which is acceptable for clinical practice.

5 Jul 2012

Botulinum toxin may help prevent arm tremor in people with MS

Botulinum toxin may help prevent shaking or tremor in the arms and hands of people with multiple sclerosis (MS), according to new research published in the July 3, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology.

3 Jul 2012

High medical illness rates in bipolar disorder

Results from a US study show that more than half of patients with bipolar disorder have a significant burden of comorbid medical illnesses.

28 Jun 2012

Potential risk factors for disorder that causes people to kick or punch during sleep

Smoking, head injury, pesticide exposure, farming and less education may be risk factors for a rare sleep disorder that causes people to kick or punch during sleep, according to a study published in the June 27, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Jun 2012

Arena receives FDA approval for Belviq to treat obesity

The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.

28 Jun 2012

CHRI signs new sales LOI with Pengxi Huitong Pharmaceutical

China Health Resource, Inc., announced today that it has signed a new sales letter of intent (LOI) for this year for its proprietary Yishen Capsule valued at 25 million RMB; approximately $4 million USD.

26 Jun 2012

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] as a treatment for multifocal motor neuropathy (MMN). This is the first immunoglobulin treatment approved for MMN patients in the United States, and it was approved for use with MMN patients in Europe in 2011.

From Baxter International Inc. 25 Jun 2012

MAP Pharmaceuticals completes End-of-Review meeting with FDA for LEVADEX NDA

MAP Pharmaceuticals, Inc. today announced that the Company completed an End-of-Review meeting with the United States Food and Drug Administration (FDA) for its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

25 Jun 2012

Data from MAP Pharmaceuticals’ LEVADEX clinical studies to be presented at AHS meeting

MAP Pharmaceuticals, Inc. today announced that the Company will present data on LEVADEX (formerly MAP0004), an orally inhaled investigational drug for the acute treatment of migraine, at the 54th Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, CA, June 21-24, 2012.

22 Jun 2012

Migraine News and Research

Latest Migraine News and Research

Migraines not associated with cognitive decline

Fainting appears to have strong genetic predisposition

Caffeine may ease movement symptoms of Parkinson's

Health Union releases results of 'Migraine In America 2012' study

Insomnia: an interview with Dr Darryle Schoepp

Watching YouTube videos may help treat benign paroxysmal positional vertigo

New AAN guideline recommends several treatments for people with Huntington's chorea

High ceramide levels may increase a person's risk of AD

Vivus receives FDA approval for Qsymia to manage chronic weight

Migraine involves multiple symptoms that vary widely among sufferers

Stress management program may help people with MS prevent new disease activity

Non-invasive absolute intracranial pressure value meter shown to be accurate in clinical settings

Botulinum toxin may help prevent arm tremor in people with MS

High medical illness rates in bipolar disorder

Potential risk factors for disorder that causes people to kick or punch during sleep

Arena receives FDA approval for Belviq to treat obesity

CHRI signs new sales LOI with Pengxi Huitong Pharmaceutical

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

MAP Pharmaceuticals completes End-of-Review meeting with FDA for LEVADEX NDA

Data from MAP Pharmaceuticals’ LEVADEX clinical studies to be presented at AHS meeting

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Migraine News and Research

Latest Migraine News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in